Deep dive
How digital healthtech startups can gain investor trust: Pier interviewed by Luxinnovation
08.05.2026
Our progress journal.
Portfolio
niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia
07.05.2026
Team
Roel van Wegberg promoted to Partner
23.04.2026
Deep dive
Impactful capital in practice: Roel & Carmel on a Delfin podcast on impact investing
13.04.2026
Deep dive
Investing in health is not impact investing
25.03.2026
Portfolio
Vivalyx announces First-in-Human use of Vivalyx Omnisol® in kidney transplant clinical trial
17.03.2026
Portfolio
Portfolio company Corporis Medical begins patient enrolment in clinical investigation of Laprixa
16.03.2026
Portfolio
Psylaris: bringing VR-powered trauma therapy to Ukraine
26.02.2026
Team
Carmel van den Berk joins the BVP Health team
25.02.2026
Deep dive
Turning scarcity into opportunity: a breakthrough for organ donation
10.02.2026
Portfolio
PectCof (NL) secures a positive EFSA scientific opinion for Dutch Gum as a novel food ingredient
27.01.2026
Portfolio
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
11.12.2025
Portfolio
Lely invests in Dutch scale-up Grassa
09.12.2025
Portfolio
Exit: Fortimedix Surgical acquired by Medtronic
01.12.2025
Portfolio
Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform
26.11.2025
Portfolio
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13.11.2025
Portfolio
Qorium secures €22m investment to accelerate cultivated leather commercialisation
11.11.2025
New deal
Psylaris secures new investment to expand digital mental health solutions across Europe
22.10.2025
Team
BVP 2024 Impact Report Now Available!
14.10.2025
Deep dive
ReSolved Technologies: “Confidence in the product and the partnership!”
06.10.2025
Deep dive
AVL Motion: “Aiming to solve the major challenge: labour shortages!”
02.09.2025
Portfolio
Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project
26.06.2025
Portfolio
Hy2Care secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion
14.05.2025
Portfolio
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
17.04.2025